NO306930B1 - Anvendelse av 2-amino-6-n-propylamino-4,5,6,7- tetrahydrobenzotiazol (Pramipexol) som et antidepressivt middel - Google Patents

Anvendelse av 2-amino-6-n-propylamino-4,5,6,7- tetrahydrobenzotiazol (Pramipexol) som et antidepressivt middel

Info

Publication number
NO306930B1
NO306930B1 NO952207A NO952207A NO306930B1 NO 306930 B1 NO306930 B1 NO 306930B1 NO 952207 A NO952207 A NO 952207A NO 952207 A NO952207 A NO 952207A NO 306930 B1 NO306930 B1 NO 306930B1
Authority
NO
Norway
Prior art keywords
antidepressant
tetrahydrobenzothiazole
pramipexole
propylamino
amino
Prior art date
Application number
NO952207A
Other languages
English (en)
Other versions
NO952207L (no
NO952207D0 (no
Inventor
Rudolf Hammer
Joachim Mierau
Erich Lehr
Franco Borsini
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of NO952207L publication Critical patent/NO952207L/no
Publication of NO952207D0 publication Critical patent/NO952207D0/no
Publication of NO306930B1 publication Critical patent/NO306930B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
NO952207A 1992-12-05 1995-06-02 Anvendelse av 2-amino-6-n-propylamino-4,5,6,7- tetrahydrobenzotiazol (Pramipexol) som et antidepressivt middel NO306930B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4241013A DE4241013A1 (de) 1992-12-05 1992-12-05 Verwendung von 2-Amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazol als Arzneimittel mit antidepressiver Wirkung
PCT/EP1993/003389 WO1994013287A1 (de) 1992-12-05 1993-12-02 Verwendung von 2-amino-6-a-propyl-amino-4,5,6,7-tetrahydrobenzothiazol (pramipexol) als arzneimittel mit antidepressiver wirkung

Publications (3)

Publication Number Publication Date
NO952207L NO952207L (no) 1995-06-02
NO952207D0 NO952207D0 (no) 1995-06-02
NO306930B1 true NO306930B1 (no) 2000-01-17

Family

ID=6474503

Family Applications (1)

Application Number Title Priority Date Filing Date
NO952207A NO306930B1 (no) 1992-12-05 1995-06-02 Anvendelse av 2-amino-6-n-propylamino-4,5,6,7- tetrahydrobenzotiazol (Pramipexol) som et antidepressivt middel

Country Status (29)

Country Link
US (1) US6191153B1 (no)
EP (1) EP0675717B1 (no)
JP (1) JP3221880B2 (no)
KR (1) KR100311165B1 (no)
CN (1) CN1052400C (no)
AT (1) ATE183091T1 (no)
AU (1) AU674378B2 (no)
BG (1) BG62475B1 (no)
CA (1) CA2150131C (no)
CZ (1) CZ282679B6 (no)
DE (2) DE4241013A1 (no)
DK (1) DK0675717T3 (no)
ES (1) ES2136725T3 (no)
FI (1) FI952734A0 (no)
GR (1) GR3031521T3 (no)
HK (1) HK1019003A1 (no)
HU (1) HU221014B1 (no)
IL (1) IL107870A (no)
MX (1) MX9307644A (no)
NO (1) NO306930B1 (no)
NZ (1) NZ258876A (no)
PL (1) PL309282A1 (no)
RU (1) RU2157685C2 (no)
SG (1) SG49228A1 (no)
SK (1) SK281441B6 (no)
TW (1) TW362973B (no)
UA (1) UA35604C2 (no)
WO (1) WO1994013287A1 (no)
ZA (1) ZA939065B (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6156777A (en) 1994-12-15 2000-12-05 Pharmacia & Upjohn Company Use of pramipexole as a neuroprotective agent
US5650420A (en) * 1994-12-15 1997-07-22 Pharmacia & Upjohn Company Pramipexole as a neuroprotective agent
US6001861A (en) * 1998-01-16 1999-12-14 Pharmacia & Upjohn Company Use of pramipexole in the treatment of restless legs syndrome
DE19830201A1 (de) * 1998-07-07 2000-01-13 Boehringer Ingelheim Pharma Mittel mit antidepressiver Wirkung
CA2301899C (en) * 1998-07-27 2008-11-18 Boehringer Ingelheim Pharma Kg Agent with an antidepressant activity
PE20011074A1 (es) 2000-02-23 2001-10-04 Upjohn Co Uso de pramipexol en el tratamiento de trastornos de adiccion
CA2415815A1 (en) * 2000-07-06 2002-01-17 Nigel H. Greig Tetrahydrobenzothiazole analogues as neuroprotective agents
WO2002069974A1 (en) * 2001-03-05 2002-09-12 Andrew Holman Administration of sleep restorative agents
EP1260221A3 (en) * 2001-05-23 2002-12-18 Pfizer Products Inc. Combination treatment for depression and anxiety
DE10138275A1 (de) * 2001-08-10 2003-02-27 Boehringer Ingelheim Pharma Verbindungen zur Beseitigung der Anhedonie
US8679533B2 (en) * 2002-07-25 2014-03-25 Pharmacia Corporation Pramipexole once-daily dosage form
DE102004006808A1 (de) 2004-02-11 2005-09-01 Grünenthal GmbH Substituierte 4,5,6,7-Tetrahydro-benzothiazol-2-ylamin-Verbindungen
KR101052436B1 (ko) * 2004-08-13 2011-07-29 베링거 인겔하임 인터내셔날 게엠베하 프라미펙솔 또는 약제학적으로 허용되는 이의 염을함유하는 연장 방출형 정제 제형, 이의 제조방법 및 이의용도
KR20070050081A (ko) * 2004-08-13 2007-05-14 베링거 인겔하임 인터내셔날 게엠베하 프라미펙솔 또는 약제학적으로 허용되는 이의 염을포함하는 연장 방출형 펠렛 제형, 이의 제조방법 및 이의용도
PE20061355A1 (es) * 2005-04-04 2007-01-15 Takeda Pharmaceutical Composicion farmaceutica que comprende ramelteon
WO2007045620A1 (de) * 2005-10-18 2007-04-26 Boehringer Ingelheim International Gmbh Verwendung von pramipexol zur behandlung des moderaten bis schweren restless legs syndroms (rls)
WO2007090883A1 (en) * 2006-02-10 2007-08-16 Boehringer Ingelheim International Gmbh Extended release formulation
WO2007090881A2 (en) * 2006-02-10 2007-08-16 Boehringer Ingelheim International Gmbh Modified release formulation
AU2018251604B2 (en) * 2017-04-10 2022-04-14 Chase Therapeutics Corporation NK1-antagonist combination and method for treating synucleinopathies
EP3645120A4 (en) 2017-06-30 2021-03-24 Chase Pharmaceuticals Corporation NK-1 ANTAGONIST COMPOSITIONS AND METHODS OF USE IN THE TREATMENT OF DEPRESSION
CN108802584B (zh) * 2018-06-29 2020-12-08 广东工业大学 一种变压器绝缘纸老化状态评估方法
TWI672472B (zh) * 2018-08-15 2019-09-21 鄭映芳 飲料製冰機裝置
CN110028464B (zh) * 2019-04-26 2022-11-18 浙江海洋大学 一种南极真菌次级代谢衍生物BTZ-one及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE45735T1 (de) * 1984-12-22 1989-09-15 Thomae Gmbh Dr K Tetrahydro-benzthiazole, deren herstellung und deren verwendung als zwischenprodukte oder als arnzneimittel.
DE3843227A1 (de) * 1988-12-22 1990-07-05 Boehringer Ingelheim Kg Neue verwendung von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzthiazol
DE3930282A1 (de) * 1989-09-11 1991-03-21 Boehringer Ingelheim Kg Verwendung von dopamin-autorezeptor-agonisten bei der behandlung von drogenabhaengigkeit

Also Published As

Publication number Publication date
KR950703953A (ko) 1995-11-17
KR100311165B1 (ko) 2001-12-28
DE4241013A1 (de) 1994-06-09
PL309282A1 (en) 1995-10-02
CZ144095A3 (en) 1996-03-13
US6191153B1 (en) 2001-02-20
ATE183091T1 (de) 1999-08-15
SK74095A3 (en) 1996-05-08
NO952207L (no) 1995-06-02
ES2136725T3 (es) 1999-12-01
MX9307644A (es) 1994-06-30
IL107870A0 (en) 1994-04-12
CN1052400C (zh) 2000-05-17
FI952734A (fi) 1995-06-05
ZA939065B (en) 1994-08-04
NO952207D0 (no) 1995-06-02
AU5715294A (en) 1994-07-04
UA35604C2 (uk) 2001-04-16
HK1019003A1 (en) 2000-01-14
SG49228A1 (en) 1998-05-18
NZ258876A (en) 1997-07-27
GR3031521T3 (en) 2000-01-31
HU9501623D0 (en) 1995-08-28
TW362973B (en) 1999-07-01
EP0675717A1 (de) 1995-10-11
RU2157685C2 (ru) 2000-10-20
DE59309733D1 (de) 1999-09-16
CA2150131C (en) 2004-09-21
DK0675717T3 (da) 2000-02-28
JP3221880B2 (ja) 2001-10-22
CN1091635A (zh) 1994-09-07
BG62475B1 (bg) 1999-12-30
AU674378B2 (en) 1996-12-19
JPH08504201A (ja) 1996-05-07
HUT71798A (en) 1996-02-28
SK281441B6 (sk) 2001-03-12
IL107870A (en) 1996-12-05
CA2150131A1 (en) 1994-06-23
HU221014B1 (hu) 2002-07-29
WO1994013287A1 (de) 1994-06-23
CZ282679B6 (cs) 1997-08-13
EP0675717B1 (de) 1999-08-11
FI952734A0 (fi) 1995-06-05
BG99700A (bg) 1996-04-30

Similar Documents

Publication Publication Date Title
NO306930B1 (no) Anvendelse av 2-amino-6-n-propylamino-4,5,6,7- tetrahydrobenzotiazol (Pramipexol) som et antidepressivt middel
FI905531A0 (fi) Transdermalisk anvaendning av 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobensotiazol.
NO941937D0 (no) Sakarinderivater som inhiberer proteolytiske enzymer
NO307336B1 (no) 2-[(Dihydro)pyrazolyl-3'-oksylmetylen]anilider, anvendelse derav, samt middel inneholdende forbindelsen og mellomprodukter for fremstilling av forbindelsen
FI860842A0 (fi) Labdan-derivat, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
NO930773D0 (no) Taxan-derivater, fremstilling derav, samt deres anvendelse som krefthindrende middel
BR9609653A (pt) Compostos e composições farmacêuticas contendo os mesmos
MX9203032A (es) Una solucion farmaceutica.
NO852245L (no) Anvendelse av visse forbindelser som fortilsetning.
FI793261A (fi) Farmaceutisk komposition som innehaoller 3,4-dihydro-3-oxo-2-kinoxaliner
DE69808922T2 (de) Thiazolobenzoheterocyclen, ihre herstellung und diese enthaltende phatrmazeutische zubereitungen
DK0673913T3 (da) Calcium-alkalimetalcitratforbindelser samt deres anvendelse som lægemidler
DK0587048T3 (da) Heteroarenylpiperaziner, en fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
PT1097145E (pt) Derivados de poli-hidroxialquilpirazina e sua preparacao e medicamentos que os contem
SU803375A1 (ru) Производные 5-м-нитробензилиденселеназолидиндиона-2,4, обладающие психотропной активностью
NO890069L (no) Nye makromolekylaere, overflateaktive, kvartaere, n-substituerte chitosanderivater saavel som kosmetisk middel paa basis av disse nye chitosanderivater.
NO903705D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n,n-disubstituerte arylcykloalkylaminer.

Legal Events

Date Code Title Description
MK1K Patent expired